Skip to content

The influence of differing inspired oxygen concentrations on platelet function in a model of ischaemic reperfusion injury

A trial of patients with an upper limb arterial tournique and whether an increase in inspired oxygen concentration at the time of reperfusion has any effect on platelet activation, as assessed by flow cytometry and thromboelastography

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000183280
Enrollment
45
Registered
2009-04-17
Start date
2009-03-23
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Increasing the fractional inspired oxygen concentration to 0.5 and 0.8 from 0.3 at the time of reperfusion. This is achieved by altering oxygen concentration on the ventilator. This is a one off treatment started 10 minutes before tourniquet release and continued until 30 minutes after tourniquet release.

Sponsors

Royal Perth Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Adult patients undergoing upper limb surgery that requires the use of a tourniquet for more than 45 minutes 2. American Society of Anaesthesiology (ASA) grade 1 or 2

Exclusion criteria

1. Patients taking any antiplatelet medication 2. Confirmed coagulation disorder (pathological or drug induced) 3. Platelet count less then 80 x 109/l 4. Blood urea greater than 8.0 mmol/L 5. Systemic infection 6. Confirmed systemic Inflammatory diseases 7. Documented pregnancy 8. Documented malignancy 9. Trauma other than the ipsilateral upper limb 10. Multiple tourniquet episodes 11. Likely intraoperative O2 requirement > 30%

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026